CRUCIANI, Gabriele
CRUCIANI, Gabriele
DIPARTIMENTO DI CHIMICA, BIOLOGIA E BIOTECNOLOGIE
1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 1): action in ion channels and GPCRs
2011 Ioan, P; Carosati, Emanuele; Micucci, M; Cruciani, Gabriele; Broccatelli, Fabio; Zhorov, Bs; Chiarini, A; Budriesi, R.
1,4-Dihydropyridine Scaffold in Medicinal Chemistry, The Story So Far And Perspectives (Part 2): Action in Other Targets and Antitargets
2012 Carosati, Emanuele; P., Ioan; M., Micucci; Broccatelli, Fabio; Cruciani, Gabriele; B. S., Zhorov; A., Chiarini; R., Budriesi
3D QSAR of Mutagenic Heterocyclic Amines that are Substrates of Cytochrome P458 1A2
2000 Lozano, J.; Pastor, M.; Gago, F.; Cruciani, Gabriele; Centeno, N.; Sanz, F.
3D-QSAR GRID Descriptors and Chemometric Tools in the development of Selective Antagonists of Muscarinic Receptor
2000 Gratteri, P.; Cruciani, Gabriele; Scapecchi, S.; Romanelli, M.; Melani, F.
3D-QSAR methods on the basis of ligand-receptor complexes. Application of COMBINE and GRID/GOLPE methodologies to a series of CYP1A2 ligands
2000 Lozano, J.; Pastor, M.; Cruciani, Gabriele; Gaedt, K.; Centeno, N.; Gago, F.; Sanz, F.
6-Aminoquinolones: a New Class of Quinolone Antibacterials?
1995 Cecchetti, Violetta; Clementi, Sergio; Cruciani, Gabriele; Fravolini, Arnaldo; P. G., Pagella; A., Savino; Tabarrini, Oriana
6-Substituted Benzopyrans as Potassium Channel Activators: Synthesis, Vasodilator Properties, and Multivariate Analysis
1999 Mannhold, R.; Cruciani, Gabriele; Weber, H.; Lemoine, H.; Derix, A.; Weichel, C.; Clementi, M.
A 3D-QSAR Study on the Srtuctural Requirements for Binding to CB1 and CB2 Cannabinoid Receptors
2000 Fichera, M.; Cruciani, Gabriele; Bianchi, A.; Musumarra, G.
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction
2015 Massari, Serena; Nannetti, Giulio; Desantis, Jenny; Muratore, Giulia; Sabatini, Stefano; Manfroni, Giuseppe; Mercorelli, Beatrice; Cecchetti, Violetta; Palù, Giorgio; Cruciani, Gabriele; Loregian, Arianna; Goracci, Laura; Tabarrini, Oriana
A chemometric approach for evaluating the efficiency of a pilot plant for MSW combustion
1991 Cruciani, Gabriele; Clementi, Sergio; D., Pitea; M., Lasagni; R., Todeschini
A Common Reference Framework for Analyzing/Comparing Proteins and Ligands. Fingerprints for Ligands and Proteins (FLAP): Theory and Application
2007 Baroni, Massimo; Cruciani, Gabriele; Sciabola, Simone; Perruccio, F.; Mason, J.
A comparative chemometric study of QSAR descriptors
1990 Bonelli, Daniela; Coata, Giuliana; Clementi, Sergio; Cruciani, Gabriele; M., Marsili
A comparative study of the antimicrobial and antioxidant activities of Inonotus hispidus fruit and their mycelia extracts
2019 Angelini, P.; Girometta, C.; Tirillini, B.; Moretti, S.; Covino, S.; Cipriani, M.; D'Ellena, E.; Angeles, G.; Federici, E.; Savino, E.; Cruciani, G.; Venanzoni, R.
A computational study toward the “personalized” activity of alternariol – Does it matter for safe food at individual level?
2019 Dellafiora, L.; Galaverna, G.; Cruciani, G.; Dall'Asta, C.
A liquid chromatography-high resolution mass spectrometry method for the determination of thirty-three per- and polyfluoroalkyl substances in animal liver
2020 Barola, C.; Moretti, S.; Giusepponi, D.; Paoletti, F.; Saluti, G.; Cruciani, G.; Brambilla, G.; Galarini, R.
A new class of selective myocardial calcium channel modulators. 2. Role of the acetal chain in oxadiazol-3-one derivatives.
2005 Budriesi, R.; Carosati, Emanuele; Chiarini, A.; Cosimelli, B.; Cruciani, Gabriele; Ioan, P.; Spinelli, D.; Spisani, R.
A new set of Principal Properties for Heteroaromatics obtained by GRIDQuant. Struct.-Act. Relat., 15, 108-120 (1996).
1996 Clementi, Sergio; Cruciani, Gabriele; P., Fifi; D., Riganelli; Valigi, Roberta; G., Musumarra
A Novel Approach for Predicting P-Glycoprotein (ABCB1) Inhibition Using Molecular Interaction Fields
2011 Broccatelli, Fabio; Carosati, Emanuele; A., Neri; M., Frosini; Goracci, Laura; T. I., Oprea; Cruciani, Gabriele
A Novel Lipidomics-Based Approach to Evaluating the Risk of Clinical Hepatotoxicity Potential of Drugs in 3D Human Microtissues
2020 Goracci, L.; Valeri, A.; Sciabola, S.; Aleo, M. D.; Moritz, W.; Lichtenberg, J.; Cruciani, G.
A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth
2020 Celegato, Marta; Messa, Lorenzo; Goracci, Laura; Mercorelli, Beatrice; Bertagnin, Chiara; Spyrakis, Francesca; Suarez, Irina; Cousido-Siah, Alexandra; Travé, Gilles; Banks, Lawrence; Cruciani, Gabriele; Palù, Giorgio; Loregian, Arianna
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 1): action in ion channels and GPCRs | 2011 | Ioan, P; Carosati, Emanuele; Micucci, M; Cruciani, Gabriele; Broccatelli, Fabio; Zhorov, Bs; Chiarini, A; Budriesi, R. | |
| 1,4-Dihydropyridine Scaffold in Medicinal Chemistry, The Story So Far And Perspectives (Part 2): Action in Other Targets and Antitargets | 2012 | Carosati, Emanuele; P., Ioan; M., Micucci; Broccatelli, Fabio; Cruciani, Gabriele; B. S., Zhorov; A., Chiarini; R., Budriesi | |
| 3D QSAR of Mutagenic Heterocyclic Amines that are Substrates of Cytochrome P458 1A2 | 2000 | Lozano, J.; Pastor, M.; Gago, F.; Cruciani, Gabriele; Centeno, N.; Sanz, F. | |
| 3D-QSAR GRID Descriptors and Chemometric Tools in the development of Selective Antagonists of Muscarinic Receptor | 2000 | Gratteri, P.; Cruciani, Gabriele; Scapecchi, S.; Romanelli, M.; Melani, F. | |
| 3D-QSAR methods on the basis of ligand-receptor complexes. Application of COMBINE and GRID/GOLPE methodologies to a series of CYP1A2 ligands | 2000 | Lozano, J.; Pastor, M.; Cruciani, Gabriele; Gaedt, K.; Centeno, N.; Gago, F.; Sanz, F. | |
| 6-Aminoquinolones: a New Class of Quinolone Antibacterials? | 1995 | Cecchetti, Violetta; Clementi, Sergio; Cruciani, Gabriele; Fravolini, Arnaldo; P. G., Pagella; A., Savino; Tabarrini, Oriana | |
| 6-Substituted Benzopyrans as Potassium Channel Activators: Synthesis, Vasodilator Properties, and Multivariate Analysis | 1999 | Mannhold, R.; Cruciani, Gabriele; Weber, H.; Lemoine, H.; Derix, A.; Weichel, C.; Clementi, M. | |
| A 3D-QSAR Study on the Srtuctural Requirements for Binding to CB1 and CB2 Cannabinoid Receptors | 2000 | Fichera, M.; Cruciani, Gabriele; Bianchi, A.; Musumarra, G. | |
| A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction | 2015 | Massari, Serena; Nannetti, Giulio; Desantis, Jenny; Muratore, Giulia; Sabatini, Stefano; Manfroni, Giuseppe; Mercorelli, Beatrice; Cecchetti, Violetta; Palù, Giorgio; Cruciani, Gabriele; Loregian, Arianna; Goracci, Laura; Tabarrini, Oriana | |
| A chemometric approach for evaluating the efficiency of a pilot plant for MSW combustion | 1991 | Cruciani, Gabriele; Clementi, Sergio; D., Pitea; M., Lasagni; R., Todeschini | |
| A Common Reference Framework for Analyzing/Comparing Proteins and Ligands. Fingerprints for Ligands and Proteins (FLAP): Theory and Application | 2007 | Baroni, Massimo; Cruciani, Gabriele; Sciabola, Simone; Perruccio, F.; Mason, J. | |
| A comparative chemometric study of QSAR descriptors | 1990 | Bonelli, Daniela; Coata, Giuliana; Clementi, Sergio; Cruciani, Gabriele; M., Marsili | |
| A comparative study of the antimicrobial and antioxidant activities of Inonotus hispidus fruit and their mycelia extracts | 2019 | Angelini, P.; Girometta, C.; Tirillini, B.; Moretti, S.; Covino, S.; Cipriani, M.; D'Ellena, E.; Angeles, G.; Federici, E.; Savino, E.; Cruciani, G.; Venanzoni, R. | |
| A computational study toward the “personalized” activity of alternariol – Does it matter for safe food at individual level? | 2019 | Dellafiora, L.; Galaverna, G.; Cruciani, G.; Dall'Asta, C. | |
| A liquid chromatography-high resolution mass spectrometry method for the determination of thirty-three per- and polyfluoroalkyl substances in animal liver | 2020 | Barola, C.; Moretti, S.; Giusepponi, D.; Paoletti, F.; Saluti, G.; Cruciani, G.; Brambilla, G.; Galarini, R. | |
| A new class of selective myocardial calcium channel modulators. 2. Role of the acetal chain in oxadiazol-3-one derivatives. | 2005 | Budriesi, R.; Carosati, Emanuele; Chiarini, A.; Cosimelli, B.; Cruciani, Gabriele; Ioan, P.; Spinelli, D.; Spisani, R. | |
| A new set of Principal Properties for Heteroaromatics obtained by GRIDQuant. Struct.-Act. Relat., 15, 108-120 (1996). | 1996 | Clementi, Sergio; Cruciani, Gabriele; P., Fifi; D., Riganelli; Valigi, Roberta; G., Musumarra | |
| A Novel Approach for Predicting P-Glycoprotein (ABCB1) Inhibition Using Molecular Interaction Fields | 2011 | Broccatelli, Fabio; Carosati, Emanuele; A., Neri; M., Frosini; Goracci, Laura; T. I., Oprea; Cruciani, Gabriele | |
| A Novel Lipidomics-Based Approach to Evaluating the Risk of Clinical Hepatotoxicity Potential of Drugs in 3D Human Microtissues | 2020 | Goracci, L.; Valeri, A.; Sciabola, S.; Aleo, M. D.; Moritz, W.; Lichtenberg, J.; Cruciani, G. | |
| A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth | 2020 | Celegato, Marta; Messa, Lorenzo; Goracci, Laura; Mercorelli, Beatrice; Bertagnin, Chiara; Spyrakis, Francesca; Suarez, Irina; Cousido-Siah, Alexandra; Travé, Gilles; Banks, Lawrence; Cruciani, Gabriele; Palù, Giorgio; Loregian, Arianna |